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Abstract
Objective: To assess the extent to which the observed racial disparities in cardiac revascularization use can be explained by
the variation across counties where patients live, and how the within-county racial disparities is associated with the local
hospital capacity.
Data Sources: Administrative data from Pennsylvania Health Care Cost Containment Council (PHC4) between 1995 and
2006.
Study Design: The study sample included 207,570 Medicare patients admitted to hospital for acute myocardial infarction
(AMI). We identified the use of coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI)
procedures within three months after the patient’s initial admission for AMI. Multi-level hierarchical models were used to
determine the extent to which racial disparities in procedure use were attributable to the variation in local hospital capacity.
Principal Findings: Blacks were less likely than whites to receive CABG (9.1% vs. 5.8%; p,0.001) and PCI (15.7% vs. 14.2%;
p,0.001). The state-level racial disparity in use rate decreases for CABG, and increases for PCI, with the county adjustment.
Higher number of revascularization hospitals per 1,000 AMI patients was associated with smaller within-county racial
differences in CABG and PCI rates. Meanwhile, very low capacity of catheterization suites and AMI hospitals contributed to
significantly wider racial gap in PCI rate.
Conclusions: County variation in cardiac revascularization use rates helps explain the observed racial disparities. While
smaller hospital capacity is associated with lower procedure rates for both racial groups, the impact is found to be larger on
blacks. Therefore, consequences of fewer medical resources may be particularly pronounced for blacks, compared with
whites.
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understand the unintended effects of the changes in medical
resources on racial disparities of medical utilization.
Cardiac revascularization procedures, comprising coronary
artery bypass graft (CABG) and percutaneous coronary interventions (PCI) are the most commonly performed medical procedures
in the U.S. About 1 million adults undergo CABG and PCI
annually [9], with more than half of these procedures performed
for elderly patients over age 65 [10]. Large racial inequalities in
the provision of cardiac revascularization procedures are consistently documented in the literature, and such differences cannot be
fully explained by heterogeneity in patient clinical presentations,
socioeconomic status, insurance coverage, and preferences [11–
19]. Previous studies have pointed out that racial disparities are
often attributed to where patients live: the medical utilization
among minority populations are lower on average because they
tend to cluster in geographic areas with lower utilization rates for
all racial groups [20,21]. While these studies underscored the
importance of geography in the measurement of racial disparity,

Introduction
The considerable geographic variation in medical spending has
raised widespread concerns about the inefficiency of the United
States healthcare system. Although the abundance of medical
resources, such as specialty physicians and hospital beds, have
been shown to be associated with greater treatment intensity for
chronically ill patients [1–3], studies disagree on whether higher
utilization translates into better patient outcomes [4,5]. This
phenomenon has led to various policy initiatives that have focused
on provider incentives to curtail the overuse of resource-intensive
services, such as reducing Medicare reimbursement for hospitals
and surgeons [6], and strengthening regulatory approaches to limit
new hospital services. On the other hand, many are concerned
that aggressive policy changes could lead to a shortage of surgeons
and hospitals, consequently threatening patient access to care
[7,8]. To the extent that minority populations are particularly
vulnerable to inadequate access to care, it is important to
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there has been limited discussion of the potential causes of withinarea racial disparities. Some researchers found evidence that local
factors such as lower income and higher degree of residential
segregation could lead to wider racial gaps in medical utilization
[21], yet little is known about the influence of hospital capacity.
In this study, we examined the relationship between local
medical resources and racial disparity in cardiac revascularization
utilization by analyzing the use of CABG and PCI among
Pennsylvania Medicare beneficiaries from 1995 to 2006. Specifically, we sought to address two questions: (1) To what extent can
the state-level racial disparities in the rates of CABG and PCI be
explained by variations in procedure rates across counties? (2) Are
the within-county racial disparities in procedure rates attributable
to local hospital capacity?

graphic characteristics included gender, age group (,65, 65–75
and .75), primary payer type (Medicare managed care plan, or
others), secondary expected payer type (Medicaid, private
insurance, or others), and log of median household income at
the patient’s zip code of residence, which was obtained by linking
patient zip code to the US Census 2000 Summary File 3. To
adjust for patient illness severity and preexisting conditions, we
included the count of comorbid conditions according to AHRQ
Elixhauser comorbidity diagnostic categories [24] and dummy
variables of major clinical indications affecting the quality of
CABG/PCI procedures (hypertension, heart failure, cardiogenic
shock, cancer, renal failure, other coronary artery diseases, history
of CABG/PCI procedure). We also considered the source of
admission: whether the patient was admitted from an emergency
department, and whether the patient was transferred from another
health care facility (hospital, skilled nursing facility, intermediate
care facility, or assisted living facility); the reference group
consisted of patients directly admitted to hospital.
In the main analysis, we used the number of revascularization
hospitals per 1,000 AMI patients in each county to measure local
hospital capacity. Following prior literature, we defined revascularization hospitals as those that performed at least 5 CABG or
PCI procedures annually [12]. Hospitals that performed PCI but
did not perform CABG were also counted because such facilities
represented a nontrivial proportion of access to cardiac care
services in nonurban areas [25]. To detect any non-linear
relationship between the hospital capacity and procedure rates,
we coded the number of hospitals per capita into quintile
categories.

Methods
Data and Sample
This study performed a retrospective analysis using the
administrative data from Pennsylvania Health Care Cost Containment Council (PHC4). The PHC4 collects detailed patient
demographic and utilization information, including age, gender,
race, diagnosis and procedure codes, diagnosis related groups
(DRGs), and source of admission, for all hospital discharges
occurring in all Pennsylvania hospitals.
The sample for this analysis was comprised of Medicare
beneficiaries (patients with Medicare listed as the primary
expected payer) admitted with a new primary diagnosis of AMI,
defined as the International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM) code of 410.xx,
between 1995 and 2006. We focused on the Medicare population
in order to eliminate the substantial heterogeneity in health
insurance coverage that affects the likelihood of receiving
surgeries. Patients who were admitted with the same illness in
the prior year or for subsequent episodes of care (ICD-9-CM
410.x2) were excluded. This analysis was limited to AMI patients
who resided in Pennsylvania, and who were Black or White. Other
racial groups including Asian or Pacific Islander, Hispanic
American Indian or Eskimo, and other or unknown race were
excluded due to low numbers of observations. Collectively, these
patients accounted for 7.7% of all Pennsylvanian AMI patients.
Patients were linked over time via a unique patient ID, which
enabled us to identify the procedure used following the first AMI
admission.

Statistical Analyses
We first compared the average procedure rates and baseline
characteristics between the two racial groups using tests adjusted
for clustering of patients within counties. We then performed a
series of regression analyses on the use of CABG and PCI
procedures. The initial model is a linear probability regression of
the incidence of procedures on the race indicator and year
dummies, which control for secular trends of procedure rates (the
coefficient for the race dummy variable therefore identified the
‘‘raw’’ differences in procedure rates between blacks and whites).
Second, we adopted a richer specification that adjusted for
heterogeneity in the above-mentioned patient sociodemographics
and clinical characteristics. Third, to further investigate how the
estimated racial differences in procedure use might be affected by
county-level factors, we estimated a multi-level hierarchical model
with county as random effects and patient-level characteristics as
fixed effects. We employed a hierarchical model because it takes
into account the fact that revascularization procedure use for
patients within the same county may be correlated, and therefore
allows us to examine differences in procedure use among patients
within county, conditional on patient-level characteristics and
state-wide time trend. Likelihood ratio tests were used to compare
the fit of the hierarchical model over ordinary least square model.
Finally, we estimated a cross-level hierarchical model that
additionally included the random effects of county-level hospital
capacity, as well as the interaction between hospital capacity and
the patient race group. This model assumes that not only the mean
procedure rates, but also the within-county racial differences, vary
by county’s hospital capacity. It allows us to separately identify the
average within-county racial difference, the average impact of
hospital capacity on the use rate, and most importantly, the extent
to which the racial difference widens or narrows with the increase
of local hospital capacity.

Ethics Statement
The PHC4 data are hospital discharge data collected primarily
for administrative and billing purposes. Written consent was given
by the patients for their information to be stored in the hospital
database and used for research. All records are stripped of
personal identifiers. According to the HHS regulations (Code of
Federal Regulations, title 45, sec. 46.1), this research is exempt
from the HHS policy, and thus IRB approval is not required.

Outcome Measures and Covariates
The outcome measures were the individual-level use of CABG
and PCI procedures within three months of the AMI diagnosis.
The three-month cutoff is often use by prior studies to examine the
process of care for AMI patients [22,23]. Procedure use was
identified by the appearance of ICD-9-CM procedure codes
36.1X for CABG, and 36.01, 36.02, 36.05, 36.07, 36.09, or 00.66
for PCI.
The primary independent variable was patient race group,
coded as one if the patient is black. Other patient sociodemoPLOS ONE | www.plosone.org
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We initially estimated hierarchical models with binomial logit
link; however, such models were computationally infeasible due to
the large sample size. Based on previous studies, which demonstrated that the estimated marginal effects from linear probability
model and logit model tend to converge with large sample size
[26,27], we used linear hierarchical models as an alternative. To
ascertain that the linear models yield similar results as logit models,
we also estimated logit models with county fixed effects, which
allowed for a separate intercept for each of the 67 counties in our
sample. In all models the standard errors were adjusted for
clustering of patients within counties.
We performed sensitivity analyses to examine the robustness of
the findings. First, we considered the number of catheterization
suites in each county as an alternative measure of hospital
capacity. The availability of cardiac catheterization procedures in
a hospital was identified from the AHA data. We repeated the
cross-level model estimation, replacing quintiles of revascularization hospitals per capita with quintiles of catheterization suites per
capita. Second, we examined whether racial differences in
procedure use were also attributable to non-procedural hospital
resource for the AMI population, which was defined as the
number of AMI hospitals (treating at least five AMI cases during a
year) per capita in each county. Lastly, we explored the potential
impact of physician supply. Using unique IDs of operating
surgeons from the data set, we calculated the number of CABG
surgeons and PCI interventional cardiologists per capita in each
county, and then repeated the cross-level estimation.

the use of CABG. Coefficients represent percentage differences in
procedure rates. Adjusted for year trend, the likelihood of
undergoing CABG was, on average, 3.2 percentage points (95%
confidence interval (CI): 20.038–20.027), lower for blacks than
for whites. Given that the time-adjusted average use rate of CABG
was 9.1% among whites, this estimate means that blacks were
35.2% less likely to undergo CABG. Adjusting for patient
characteristics significantly reduced the racial difference to 2.4
percentage points (95% CI: 20.034–20.014), which amounted to
26.4% based on the risk-adjusted rate for whites. Controlling for
county random effects further reduced the magnitude of disparity
to 1.9 percentage points (95% CI: 20.027–20.011), suggesting
that blacks and whites in the same county were treated more
similarly than we would have assumed based on state-level riskadjusted difference. The improvement in fit compared to the
linear model was significant (x2 = 613.54, p,.0001). The FE logit
model estimated virtually the same results as the random effects
model. This set of results indicates that a significant proportion of
observed racial disparity in the CABG rate was due to black
patients, on average, living in counties with lower CABG rates
among both blacks and whites.
Among other covariates, men on average had higher CABG
rate than women; elderly Medicare patients aged between 65 and
74 were more likely to undergo CABG than those under 65; and
those who were above 75 had a significantly lower rate. Having
Medicaid listed as the secondary expected payer was associated
with a lower CABG rate, possibly reflecting that low-income
senior patients who were dually eligible for Medicare and
Medicaid have limited access to care [28]. Patients transferred
from other facilities were more likely to receive CABG, while
patients admitted through the emergency department were less
likely to. Conditional on patient sociodemographic presentation,
most of the clinical indications were significantly associated with
higher likelihood of receiving CABG.
Table 4 shows that while risk-adjustment erased the raw
difference in PCI rates (20.019 (20.028–20.01) vs. 0.002
(20.01–0.014)), further adjusting for the county-level variation
led to widened disparity (20.011 (20.023–0.001)), although the
estimate was marginally significant. Again, the likelihood ratio test
indicates a better model fit using county-specific random effects
(x2 = 1702.15, p,.0001). The FE logit results suggest that the riskadjusted difference in PCI rate did not change with the addition of
county fixed effects. These results combined suggest that, on
average, blacks might be slightly less likely to undergo PCI than
whites within the same county, but that the difference was offset by
the fact that blacks cluster in counties with relatively higher PCI
rates among both blacks and whites.
Table 5 explores the second research question, namely, whether
the within-county racial disparities are attributable to local
hospital capacity. Counties were stratified into five quintiles
according to their hospital capacity, which was defined as the
number of revascularization hospitals per 1,000 AMI patients.
Consistent with our understanding, results indicate that the local
hospital capacity contributed to higher procedure rates for both
racial groups and reduced the gap between whites and blacks.
Although the confidence interval for each of these categorical
variables overlapped with each other, we focus on comparing the
magnitudes of the coefficients in interpreting the results. Estimates
from both the hierarchical model and FE logit model indicate that
conditional on patient clinical and sociodemographic factors, those
living in counties with the larger hospital capacity were more likely
to undergo CABG and PCI. The coefficients on the interaction
terms suggest that the effect of county-level hospital capacity on
racial disparity was not linear; however, overall, increased hospital

Results
Our study sample included 195,043 (94.7%) white and 10,887
(5.3%) black Medicare enrollees, who were initially hospitalized
for AMI in 67 counties and 234 hospitals between 1995 and 2006.
Within three months of the admission, 9% of these patients
underwent CABG procedure and 15.7% underwent PCI procedure (Table 1). The use rates of both CABG and PCI were lower
among black patients. As compared with the proportion of white
patients, a higher proportion of black patients were female, aged
below 75, enrolled in Medicare managed care plans, and living in
areas with lower median household income. The black population
represented a larger proportion of patients who were dual-eligible
for the Medicaid program, a finding that probably reflects a higher
percentage of low-income Medicare enrollees among blacks. In
regard to the admission source, black patients were more likely to
be admitted through the emergency department, while white
patients were more likely to be transferred from other facilities.
Despite the lower procedure rates, black patients were significantly
sicker than white patients upon admission: they were more likely to
have two or more comorbidities, and have higher rates of
preexisting hypertension, congestive heart failure, diabetes, renal
failure, and cancer.
Table 2 shows the use of CABG and PCI among blacks and
whites in ten counties with the highest black population densities in
the study sample. In seven of the ten counties, the rate of CABG
within three months of the initial AMI diagnosis was significantly
lower for blacks than for whites. In contrast, the rate of PCI within
three months was not significantly different among blacks and
whites in six of the ten counties. In the remaining four counties,
Philadelphia had a significantly higher PCI rate among blacks
than among whites.
In Tables 3 and 4, we examine the first research question which
looks at the extent to which state-level racial disparities in CABG
and PCI rates can be explained by variations in procedure rates
across counties. Table 3 reports the adjusted racial disparities in
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Table 1. Descriptive Statistics by Racea.

Total

Whites

Blacks

(n = 207,570)

(n = 195,043)

(n = 10,887)

P Valueb

CABG within 3 months

9.0

9.1

5.8

,0.0001

PCI within 3 months

15.6

15.7

14.2

,0.0001

Male

48.3

48.6

42.6

,0.0001

Age 64-

8.1

7.6

16.9

,0.0001

Age 65–74

34.1

33.9

38.3

,0.0001

Age 75+

57.8

58.5

44.8

,0.0001

Primary payer: Medicare managed care

16.2

15.8

23.2

,0.0001

Second payer: Medicaid

5.5

4.8

18.1

,0.0001

Second payer: private insurance

41.9

42.9

25.1

,0.0001

Mean log of household incomec (SE)

10.6 (0.30)

10.6 (0.29)

10.3 (0.36)

,0.0001

Transferred admission

14.1

14.4

7.7

,0.0001

Emergency admission

72.1

71.7

80.5

,0.0001

Hypertension

43.8

43.1

55.4

,0.0001

Congestive heart failure

0.6

0.6

1.0

,0.0001

diabetes

26.6

26.2

34.4

,0.0001

Renal failure

5.8

5.4

11.9

,0.0001

cancer

2.6

2.6

3.4

,0.0001

Dependent Variable

Patient demographics and clinical history

Cardiogenic shock

4.7

4.8

3.7

,0.0001

Other coronary artery diseases

61.0

61.2

55.9

,0.0001

CABG

3.2

3.2

2.4

,0.0001

PCI

4.5

4.5

3.8

,0.0001

Elixhauser 0

19.4

19.8

12.3

,0.0001

Elixhauser 1

33.6

33.8

29.5

,0.0001

Elihauser 2

28.1

28.0

30.9

,0.0001

Elihauser 3+

18.8

18.4

27.3

,0.0001

,0.0001

Number of revascularization hospitals/1000 AMI patients
First quintile: 0–0.84

25.9

27.1

4.1

Second quintile: 0.85–2.03

14.2

14.6

6.3

,0.0001

Third quintile: 2.04–2.96

20.0

20.0

20.6

0.16

Fourth quintile: 2.97–3.89

20.1

19.1

38.7

,0.0001

Fifth quintile: 3.90+

19.8

19.2

30.3

,0.0001

Abbreviations: CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; SE, standard error.
Data are presented as percentages unless otherwise indicated.
b
t Tests.
c
Household income is abstracted at level of zip code.
doi:10.1371/journal.pone.0069855.t001
a

Because the availability of diagnostic catheterization, a standard
procedure used to determine a patient’s need for revascularization
treatment, may also affect revascularization use, we examined the
impact of the number of catheterization suites per capita as an
alternative measure of hospital capacity. Table 6 shows that higher
quintile of catheterization capacity was not significantly associated
with greater likelihood of receiving CABG, nor was it associated
with narrowed racial difference in CABG rates (i.e., the
magnitudes of cross-level interaction effects did not show a
decreasing trend across quintile groups). For PCI, the withincounty racial gap was sizable and significant only in counties with
the lowest catheterization capacity.

capacity was associated with a gradient reduction in the withincounty racial difference in CABG and PCI rates. For instance,
estimates from hierarchical models show that, all else being equal,
black patients living in counties of the lowest hospital capacity (the
first quintile) were 3.9 percentage points (95% CI: 20.065–
20.013) less likely to undergo CABG and 4.2 percentage points
(95% CI: 20.074–20.010) less likely to undergo PCI than their
white counterparts, while blacks living in counties of the largest
hospital capacity (the fifth quintile) were 2.3 percentage points
(95% CI: 20.034–20.011) less likely to undergo CABG and had
equal PCI rates with white patients (point estimate: 0.009, 95%
CI: 20.003–0.022).
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Table 2. Use of CABG and PCI in Selected Counties, By Race.

CABG Within Three Months (%)

PCI Within Three Months (%)

County

White

Black

Difference

White

Black

Difference

Philadelphia

7.0

5.6

1.4c

12.3

13.4

21.2b

Dauphin

10.0

8.4

1.6

20.0

19.9

0.1

Delaware

8.5

5.2

3.3c

13.3

11.2

2.1a

6.2

c

17.1

15.1

2.1b

b

Allegheny

9.3

3.1

Chester

7.9

4.3

3.6

15.9

16.2

20.3

Beaver

9.5

5.3

4.3b

22.0

16.3

5.7b

Monroe

7.8

4.2

3.5c

15.1

13.6

1.5

Erie

12.0

2.5

9.4c

17.2

16.9

0.3

Mercer

7.1

6.4

0.7

15.7

15.4

0.3

Washington

11.1

10.2

0.9

20.9

18.5

2.4

a

p,0.1;
p,0.05;
p,0.01 (two-tailed tests).
doi:10.1371/journal.pone.0069855.t002

b
c

Table 3. Factors Associated With CABG Use Within Three Months Among Newly Diagnose AMI patients.

Black

Year Adjusted*

+ County Random
+ Patient Characteristics Effects

FE Logit Model

Coefficient (95% CI)

Coefficient (95% CI)

Coefficient (95% CI)

c

20.032

(20.038–20.027)

20.024

c

(20.034–20.014)

Coefficient (95% CI)
(20.027–20.011)

20.022c (20.032–20.012)

0.029

c

(0.027–0.032)

0.028c

(0.026–0.031)

0.018

c

(0.013–0.022)

0.016c

(0.01–0.022)

20.019

c

0.029

c

Age 65–74

0.018

c

Age 75+

20.043c (20.050–20.036)

20.042c (20.047–20.037)

20.041c (20.047–20.036)

Primary payer: Medicare managed care

0.002

0.004b

0.004a

Male

(0.025–0.032)
(0.011–0.024)

(20.004–0.008)
c

(0.000–0.008)
c

(0–0.008)
c

Second payer: Medicaid

20.024

(20.033–20.014)

20.022

(20.028–20.017)

20.024

Second payer: private insurance

20.002

(20.011–0.008)

20.002

(20.004–0.001)

20.001

(20.009–0.007)

Log household income (zip code level)

0.006

(20.005–0.018)

0.005a

(20.000–0.011)

0.003

(20.003–0.009)

(0.051–0.070)

0.061c

(0.057–0.066)

0.039c

(0.032–0.047)

c

(20.032–20.015)

Transferred admission

0.060

Emergency admission

20.036c (20.045–20.028)

20.040c (20.044–20.037)

20.043c (20.051–20.035)

Hypertension

0.019c

0.019c

(0.016–0.022)

0.018c

(0.013–0.023)

(20.037–20.005)

20.021

(20.05–0.008)

(20.003–0.003)

0

(20.004–0.005)

Congestive heart failure

(0.014–0.024)

20.019

(20.042–0.004)

20.021

(20.005–0.004)

20.000

b

Diabetes

20.000

Renal failure

20.015c (20.021–20.008)

20.016c (20.021–20.010)

20.017c (20.023–20.01)

Cancer

20.038c (20.046–20.029)

20.037c (20.045–20.029)

20.041c (20.048–20.033)

Cardiogenic shock

0.012

b

Other coronary artery diseases

0.056c

Prior CABG

20.083c (20.090–20.077)

20.084c (20.091–20.078)

Prior PTCA

20.043c (20.049–20.038)

20.044c (20.050–20.038)

Elixhauser 1

20.000

(20.004–0.004)

Elixhauser 2

0.000

Elixhauser 3+

20.007
0.091

White, mean CABG use rate

0.091

(0.086–0.097)

(0.002–0.022)

0.010

c

(0.005–0.016)

0.014c

(0.003–0.024)

(0.050–0.063)

0.055c

(0.052–0.057)

0.058c

(0.053–0.062)

20.079c (20.082–20.077)
20.039

(20.044–20.034)

20.001

(20.004–0.003)

20.002

(20.006–0.002)

(20.006–0.007)

20.001

(20.005–0.004)

20.001

(20.007–0.006)

(20.015–0.002)

20.008c (20.013–20.003)

20.007

(20.016–0.001)

(0.085–0.096)

0.084

0.090

(0.09–0.091)

(0.079–0.089)

*Standard errors in all models are adjusted for correlation in patients living in the same county.
a
p,0.1;
b
p,0.05;
c
p,0.01 (two-tailed tests).
doi:10.1371/journal.pone.0069855.t003
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Table 4. Factors Associated With PCI Use Within Three Months Among Newly Diagnose AMI patients.

Year Adjusted*

+ County Random
+ Patient Characteristics Effects

FE Logit Model

Coefficient (95% CI)

Coefficient (95% CI)

Coefficient (95% CI)

c

0.002

(20.010–0.014)

20.011

Male

0.003a

(20.000–0.007)

0.004b

Age 65–74

20.027c (20.034–20.020)

Black

20.019

(20.028–20.010)

Coefficient (95% CI)

Age 75+

20.115

Primary payer: Medicare managed care

0.007

c

c

a

(20.023–0.001)

0

(20.017–0.016)

(0.001–0.007)

0.002

(20.001–0.005)

20.029c (20.034–20.023)

20.029

(20.035–20.023)

(20.124–20.106)

20.116c (20.122–20.111)

20.115c (20.122–20.108)

(20.011–0.025)

0.009c

(0.005–0.014)

0.008c

(20.030–20.017)

20.023c (20.035–20.011)

c

(20.003–0.018)

(20.044–20.016)

20.024

0.004

(20.012–0.020)

0.011c

(0.007–0.014)

0.011c

(0–0.022)

Log household income (zip code level)

0.032c

(0.011–0.053)

0.013c

(0.006–0.020)

0.011c

(0.003–0.018)

Transferred admission

0.069c

(0.052–0.085)

0.073c

(0.067–0.079)

0.057c

Second payer: Medicaid

20.030

Second payer: private insurance

c

(20.063–20.029)

20.051

(0.051–0.061)

0.055c

Emergency admission

20.046

Hypertension

0.056c

Congestive heart failure

20.063c (20.076–20.051)
(20.005–0.003)

c

(0.044–0.07)
c

(20.055–20.046)

20.052

(0.052–0.059)

0.057c

(0.053–0.061)

20.067c (20.086–20.047)

20.107

(20.125–20.09)

0.000

0.002

(20.002–0.007)

Diabetes

20.001

Renal failure

20.058c (20.064–20.051)

20.061c (20.067–20.054)

20.054c (20.061–20.048)

Cancer

20.018c (20.026–20.011)

20.017c (20.026–20.007)

20.023c (20.032–20.014)

c

(20.053–20.028)

20.044

(0.093–0.113)

0.097c

(20.004–0.004)

(20.063–20.04)

c

(20.051–20.037)

20.043c (20.055–20.03)

(0.094–0.101)

0.104c

Cardiogenic shock

20.040

Other coronary artery diseases

0.103c

Prior CABG

20.029c (20.037–20.020)

20.030c (20.038–20.021)

20.022c (20.029–20.016)

Prior PTCA

0.065c

0.059c

(0.052–0.066)

0.047c

(20.057–20.048)

20.065c (20.07–20.06)

(0.052–0.077)
c

Elixhauser 1

20.051

Elixhauser 2

20.085c (20.093–20.077)

Elixhauser 3+
White, mean PTCA use rate

20.115
0.157

(0.145–0.168)

0.156

c

(20.057–20.045)

20.052

c

20.087c (20.092–20.082)

(20.125–20.105)

20.117

(0.146–0.166)

0.140

c

(0.097–0.111)

(0.039–0.056)

20.098c (20.104–20.092)

(20.123–20.110)

20.124c (20.131–20.117)

(0.131–0.150)

0.156

(0.155–0.157)

*Standard errors in all models are adjusted for correlation in patients living in the same county.
a
p,0.1;
b
p,0.05;
c
p,0.01 (two-tailed tests).
doi:10.1371/journal.pone.0069855.t004

state-level racial disparity in CABG procedure decreases, and in
PCI procedure increases, with county adjustment indicate that
blacks are more likely to live in counties with lower CABG rates
and higher PCI rates for both black and white populations. Such
results are in agreement with earlier studies on the use of coronary
interventions and other procedures such as knee arthroplasty and
hip replacement, which documented wide variability of procedure
use among racial groups both within and between geographic
regions [20,21,29]. Building on prior literature, our finding
highlights the importance of controlling for small-area variations
when evaluating racial disparities in medical utilization.
Second, we find evidence that wider racial gaps in CABG and
PCI use rates within counties is attributable to county-level
hospital capacity, measured by the number of cardiac revascularization hospitals per capita. In particular, a large difference in PCI
use rate was observed in counties with very low capacity of
catheterization suites and AMI hospitals. Such findings resonate
with previous studies, which showed evidence that differences in
local medical resource supply are inversely correlated with racial
disparities in in-hospital mortality rate [30], suggesting that
consequences of fewer medical resources may be particularly
pronounced for blacks, compared with whites.
There are several potential explanations for the finding that
larger hospital capacity may have contributed to smaller racial

Similarly, Table 7 shows that the racial difference in CABG
rates remained similar in counties with different levels of AMI
hospital capacity, and that the difference in PCI rate was larger
and more significant in counties with the lowest AMI hospital
capacity. Thus, we must conclude that very low capacity of
catheterization suites and AMI hospitals contributed to wider
racial gap in the use of PCI.
Finally, Table 8 investigates whether racial disparities in
revascularization procedure use were also attributable to the level
of physician supply. The sample was stratified by the number of
CABG surgeons per capita in the CABG regressions and by the
number of PCI interventionists per capita in the PCI regressions.
Estimates in Table 8 indicate that while higher physician capacity
was strongly correlated with higher CABG and PCI use in general,
it was not systematically correlated with the size of racial gaps.

Discussion
Persistent racial disparities are well recognized by policy makers
and clinicians as a serious health system problem in need of
correction. Using inpatient claims data of Pennsylvania Medicare
beneficiaries from 1995 to 2006, we show that, first, countyvariation helps explain the differential cardiac revascularization
use between black and white AMI patients. The findings that the
PLOS ONE | www.plosone.org
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Table 5. Differences in CABG and PCI Use in Association With County-level Revascularization Hospital Capacity.

CABG Within Three Months

PCI Within Three Months

Hierarchical Model

FE Logit model

Hierarchical Model

FE Logit model

Coefficient (95% CI)

Coefficient (95% CI)

Coefficient (95% CI)

Coefficient (95% CI)

First quintile

–

–

–

–

–

–

–

–

Second quintile

0.011c

(0.003–0.019)

0.004

(20.006–0.014)

0.026c

(0.016–0.036)

0.014

(20.007–0.034)

Third quintile

0.013c

(0.006–0.019)

0.01a

(0–0.019)

0.029c

(0.021–0.038)

0.018

(20.004–0.04)

c

(0.028–0.045)

0.027

(0.004–0.049)

(0.030–0.047)

0.028

(0.006–0.05)

Revascularization Hospitals Per Capita

Fourth quintile

0.015

Fifth quintile

0.019

c
c

(0.009–0.022)

0.012

a

(0.002–0.022)

0.037

(0.013–0.026)

0.017c

(0.008–0.027)

0.038c

Interaction Effect
Black, first quintile
Black, second quintile

20.039c (20.065–20.013)
b

20.026

c

(20.048–20.004)
(20.044–20.018)

20.042c (20.064–20.02)
20.028

c

20.028

c

(20.04–20.016)
(20.032–20.024)

20.042c (20.074–20.010)
20.018
a

20.059c (20.077–20.042)

(20.044–0.009)

20.022b (20.043–20.002)

(20.028–0.002)

20.013b (20.023–20.002)

Black, third quintile

20.031

Black, fourth quintile

20.024c (20.035–20.014)

20.017c (20.029–20.005)

0.005

(20.007–0.016)

0.009

(20.007–0.024)

Black, fifth quintile

20.023c (20.034–20.011)

20.016c (20.026–20.006)

0.009

(20.003–0.022)

0.014c

(0.006–0.022)

20.013

a

p,0.1;
p,0.05;
p,0.01 (two-tailed tests).
doi:10.1371/journal.pone.0069855.t005

b
c

some extent on whether the patient is being managed by a cardiac
specialist. However, minority patients are less likely than white
patients to have access to specialists [34–36]. Given that the
referral for cardiac procedures is often influenced by the
availability of cardiac procedure service [37,38], the disparity in
access to specialty care may exacerbate the observed racial gaps in
the use rates in counties with lower cardiac hospital capacity.
Third, challenges around care coordination may also play a role in
racial differences in procedure rates. Past studies suggest that
intensive follow-up with primary care physicians (PCPs) can

gaps in procedure use. First, recent studies present evidence that
black patients are less likely to follow up with recommended, more
expensive treatments than whites [31,32]. This problem may be
worse in areas with medical resource shortages, because patients in
those areas are more likely to have insufficient awareness of where
to access the best care, and to face logistic obstacles such as
transportation costs and lack of time [33]. Second, the lack of local
medical resources may have disproportionately limited black
patients’ ability to obtain referrals and to access high-quality care.
Whether a patient obtains referrals for procedures depends to

Table 6. Differences in CABG and PCI Use in Association With County-level Catheterization Hospital Capacity.

CABG Within Three Months

PCI Within Three Months

Hierarchical Model

FE Logit model

Hierarchical Model

FE Logit model

Coefficient (95% CI)

Coefficient (95% CI)

Coefficient (95% CI)

Coefficient (95% CI)

First quintile

–

–

–

–

–

–

–

–

Second quintile

20.004

(20.010–0.001)

20.007

(20.015–0.002)

20.004

(20.010–0.003)

20.004

(20.013–0.006)

(20.008–0.003)

Catheterization Suites Per Capita

Third quintile

20.003

Fourth quintile

20.006b (20.012–20.001)

Fifth quintile

20.003

(20.009–0.003)

20.005

(20.014–0.004)

0.005

(20.002–0.013)

0.006

(20.008–0.02)

20.008

(20.023–0.007)

0.008b

(0.001–0.015)

0.01

(20.006–0.027)

20.005

(20.017–0.008)

0.013c

(0.006–0.020)

0.016a

(0–0.033)

Interaction Effect
Black, first quintile

20.030a (20.063–0.003)
c

20.036c (20.056–20.015)
c

20.048b (20.089–20.008)

20.045c (20.069–20.021)

(20.036–20.014)

0.002

(20.014–0.018)

0.012

(20.003–0.027)

(20.026–0.004)

20.007

(20.024–0.009)

0.003

(20.008–0.014)

20.004

(20.020–0.012)

20.003

(20.024–0.019)

20.012

(20.030–0.006)

20.007

(20.024–0.009)

Black, second quintile

20.022

(20.035–20.009)

20.025

Black, third quintile

20.007

(20.020–0.006)

20.011

Black, fourth quintile

20.02c

(20.034–20.009)

20.024c (20.04–20.008)

Black, fifth quintile

b

20.016

(20.031–20.001)

20.024

c

(20.038–20.01)

a

p,0.1;
p,0.05;
p,0.01 (two-tailed tests).
doi:10.1371/journal.pone.0069855.t006

b
c
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Table 7. Differences in CABG and PCI Use in Association With County-level AMI Hospital Capacity.

CABG Within Three Months

PCI Within Three Months

Hierarchical Model

FE Logit model

Hierarchical Model

FE Logit model

Coefficient (95% CI)

Coefficient (95% CI)

Coefficient (95% CI)

Coefficient (95% CI)

First quintile

–

–

–

–

–

–

–

–

Second quintile

0.001

(20.003–0.006)

0.001

(20.005–0.008)

0.011c

(0.005–0.017)

0.011b

(0.002–0.02)

Third quintile

0.010c

(0.005–0.015)

0.011b

(0.001–0.02)

0.011c

(0.005–0.018)

0.011b

(0–0.021)

(20.001–0.015)

0.017

c

(0.010–0.024)

0.016

a

(0–0.018)

0.012b

(0.003–0.020)

0.012

(20.043–20.018)

20.027b (20.050–20.003)

(20.04–20.011)

AMI Hospitals Per Capita

c

Fourth quintile

0.004

(20.002–0.010)

0.007

Fifth quintile

0.004

(20.003–0.011)

0.009b

20.018b (20.037–0.000)

20.03c

(20.001–0.033)
(20.004–0.029)

Interaction Effect
Black, first quintile

c

c

20.018a (20.039–0.003)

Black, second quintile

20.023

20.01

(20.029–0.008)

0.001

Black, third quintile

20.020c (20.032–20.008)

20.019c (20.032–20.006)

20.013

(20.030–0.003)

0

(20.023–0.023)

Black, fourth quintile

20.019b (20.034–20.004)

20.016b (20.029–20.002)

0.001

(20.019–0.021)

0.009

(20.006–0.024)

Black, fifth quintile

20.024c (20.039–20.010)

20.022c (20.034–20.011)

20.006

(20.025–0.013)

0.004

(20.011–0.019)

(20.037–20.010)

20.025

(20.022–0.024)

a

p,0.1;
p,0.05;
p,0.01 (two-tailed tests).
doi:10.1371/journal.pone.0069855.t007

b
c

procedure rates, especially among whites. This finding supports
existing research that documents large, unwanted variation in the
utilization of specialty care that is closely linked to the local health
care resource [42]. When evaluating procedures based on explicit
appropriateness classifications, numerous clinical studies find
evidence of procedural overuse among whites and underuse
among blacks [15,43,44]. Our finding provides further evidence
that the potential overutilization by whites may be driven by the
local medical service supply.

reduce racial disparities in chronic care management [39,40],
however, physicians caring for minority patients face more
difficulties in coordinating care, spending adequate time with
patients, and obtaining specialty care for their patients [41].
Moreover, care coordination tends to be more challenging in areas
with lower medical capacity as physicians’ ability to function is
further undermined by constrained resources.
Our analysis also finds a positive association between the
relative availability of cardiac revascularization services and higher

Table 8. Differences in CABG and PCI Use in Association With County-level Physician Supply.

CABG Within Three Months

PCI Within Three Months

Hierarchical Model

FE Logit model

Hierarchical Model

FE Logit model

Coefficient (95% CI)

Coefficient (95% CI)

Coefficient (95% CI)

Coefficient (95% CI)

First quintile

–

–

–

–

–

–

–

–

Second quintile

0.014c

(0.007–0.020)

0.015c

(0.005–0.026)

20.001

(20.007–0.004)

0.004

(20.004–0.012)

Third quintile

0.017c

(0.008–0.035)

0.005

Surgeons/Interventional Cardiologists Per
Capita

(0.010–0.024)

0.021c

Fourth quintile

0.009

b

(0.000–0.017)

0.017

c

(20.001–0.011)

0.008a

(20.001–0.017)

(0.005–0.029)

0.008

b

(0.000–0.016)

0.012b

Fifth quintile

0.019c

(0.009–0.028)

0.033c

(0.002–0.022)

(0.018–0.049)

0.018c

(0.008–0.027)

0.023b

(0.004–0.041)

Black, first quintile

0.005

(20.007–0.018)

20.017b (20.034–0)

Black, second quintile

0.006

(20.012–0.024)

0.01

(20.002–0.023)

20.015b (20.029–20.001)

20.024c (20.036–20.013)

0.002

(20.015–0.018)

0.005

(20.015–0.025)

Black, third quintile

20.019a (20.039–0.002)

20.033c (20.047–20.02)

20.003

(20.027–0.021)

20.009a (20.019–0.001)

Black, fourth quintile

20.008

(20.031–0.014)

20.023b (20.042–20.003)

20.020

(20.045–0.006)

20.013

(20.036–0.009)

Black, fifth quintile

20.012

(20.039–0.015)

20.016a (20.032–0.001)

20.013

(20.045–0.020)

20.011

(20.029–0.007)

Interaction Effect

a

p,0.1;
p,0.05;
p,0.01 (two-tailed tests).
doi:10.1371/journal.pone.0069855.t008

b
c
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The results of our study provide important policy implications
for addressing the health disparities among minority populations.
For discretionary surgical procedures, policy should not simply
focus on equalizing black rates with white rates. Instead, the
objective depends critically on whether the racial gap stems from
excessive utilization among whites or underutilization among
blacks [14,15,43]. Where evidence suggests underutilization
among minorities, care coordination and referral practices must
be improved to ensure minority patients are receiving appropriate
care. Equally important is ensuring white patients are not
overutilizing services simply because of their availability. In the
era of evidence-based medicine, such variation speaks to the need
to reduce subjective decision making by continuing education of
practicing professionals on the usefulness and appropriateness of
different treatments and the importance of following evidencebased guidelines.
However, since cardiac procedures are well-reimbursed and the
current fee-for-service (FFS) payment system rewards providers
based on volume rather than appropriate and efficient use, it is
difficult to effectively reduce the overuse of cardiac procedures
merely with clinical decision-support guidelines. We believe that
the emerging models of bundled or episode-based payment system
could potentially address both the overuse and underuse problems
and improve the efficiency of care delivery. Unlike the FFS
payment, which covers the services by each provider separately,
bundled payment covers a certain clinical episode or a defined
time period [45], thereby ensuring that the financial risk and
benefit are shared by hospitals, physicians, and patients, and
encouraging providers to provide appropriate and efficient care for
all patients. A recent demonstration project conducted by
Geisinger’s ProvenCare shows that the bundled payment model
significantly reduced hospital spending on CABG during a fiveyear period [46]. Because performance incentives are an
important part of the model, measures related to clinical quality,
patient experience, and cost efficiency need to be established.
Therefore, providers will need significant infrastructure including
electronic health records (EHRs) to be able to provide the quality
information necessary for obtaining rewards of improved efficiency.
An important limitation of this analysis is our focus on Medicare
beneficiaries. Although this approach greatly eliminates heteroge-

neity in health coverage among non-Medicare patients, we are
unable to ascertain the effects of geography on racial disparities
among other populations. Others have suggested that patients with
private insurance or those insured through the Medicaid program
may face different levels of disparities in care [47,48]. The second
limitation is that the inpatient claims data used for this analysis are
collected primarily for billing purposes, and thus clinical details are
limited. As a result, although we attempt to control for patient
comorbidities, our specification lacks measures of detailed medical
history and laboratory results that are used by physicians in
making treatment decisions. Third, because the smallest time unit
in the PHC4 data is quarter, we are not able to examine treatment
patterns in a shorter time frame such as 30-day procedure
incidence. Finally, our findings can be generalized only to
populations that are similar in their characteristics to those in
Pennsylvania. Future research is needed to replicate our findings
in states with large black rural population such as Mississippi and
Louisiana to determine the disparity in utilization by race and the
extent to which county-level medical capacity differences account
for such disparity.
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